CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B902. A total of 5 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,762,462 | +58.6% | 196,600 | 0.0% | 0.45% | +41.2% |
| Q3 2022 | $5,526,000 | -65.5% | 196,600 | -66.9% | 0.32% | -65.6% |
| Q2 2022 | $16,036,000 | +18.7% | 594,800 | +50.0% | 0.93% | +112.6% |
| Q1 2022 | $13,508,000 | -11.3% | 396,600 | +0.6% | 0.44% | -20.7% |
| Q4 2021 | $15,236,000 | – | 394,300 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 594,800 | $16,036,000 | 0.93% |
| SIMPLEX TRADING, LLC | 369,400 | $9,959,000 | 0.01% |
| JANE STREET GROUP, LLC | 479,400 | $12,925,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 127,400 | $3,435,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |